Insufficient evidence intraperitoneal fluid is equivalent or superior to intravenous fluid therapy in dehydrated calves
a Knowledge Summary by
Allan Gunn BVM&S, MANZCVS, DACT, MRCVS1*
Timothy Crawshaw BVetMed, MSc1
Victoria Brookes BVM&S, MANZCVS, PhD, MRCVS1
1School of Animal and Veterinary Sciences, Charles Sturt University, Wagga Wagga, NSW, Australia & Graham Centre for Agricultural Innovation, (NSW DPI and CSU), Pugsley Place, Wagga Wagga, Australia
*Corresponding Author (algunn@csu.edu.au)
Vol 5, Issue 1 (2020)
Published: 11 Feb 2020
Reviewed by: Virginia Sherwin (MA, VetMB, MVM Dip., ECBHM, MRCVS)and Dai Grove-White (BVSc, MSc, DBR, PhD, DECBHM, FRCVS)
Next review date: 18 Jul 2020
DOI: 10.18849/VE.V5I1.218
PICO question
In calves < 14 days old which are moderately to severely dehydrated (5–9%) or acidaemic (base excess -5 to -15 mM), does intraperitoneal fluid therapy result in comparable or superior clinical improvement when compared to intravenous fluid therapy?
Clinical bottom line
Category of research question
Treatment
The number and type of study designs reviewed
Two papers were critically reviewed (one randomised clinical trial and one case series)
Strength of evidence
Weak evidence relevant to the topic question
Outcomes reported
Statistically significant differences were not found between treatment groups (administration of intravenous fluids [n = 27] or intra-peritoneal fluids [n = 28]) in the clinical trial, and findings relevant to the topic question were not reported in the case series of 18 calves
Conclusion
These studies provide insufficient evidence that intraperitoneal (IP) fluid is comparable to, or provides superior clinical improvement, when compared to intravenous (IV) fluid therapy in moderately to severely dehydrated (5–9 %) or acidaemic calves (base excess -5 to -15 mM) aged < 14 days of age
How to apply this evidence in practice
The application of evidence into practice should take into account multiple factors, not limited to: individual clinical expertise, patient’s circumstances and owners’ values, country, location or clinic where you work, the individual case in front of you, the availability of therapies and resources.
Knowledge Summaries are a resource to help reinforce or inform decision making. They do not override the responsibility or judgement of the practitioner to do what is best for the animal in their care.
Clinical scenario
A group of diarrhoeic calves <14 days old are presented for clinical examination and treatment. The calves are in differing stages of dehydration and mentation. Fluid therapy is indicated. In mildly affected calves, oral rehydration therapy will probably suffice, whilst the moderately to severely affected calves will require parenteral intravenous fluid therapy, and potentially supplementary bicarbonate to treat acidaemia. Intravenous fluid therapy can be time consuming and expensive. In moderately dehydrated or acidaemic calves, would intraperitoneal fluid administration be as least as clinically beneficial as intravenous fluid therapy?
The evidence
Two studies were identified in which IP fluid was administered to dehydrated calves. Koenig et al. (1995) describe a randomised controlled trial in which 55 calves received either IP or IV fluid. Correction of dehydration and acidaemia was not assessed; instead, longer-term impacts (weight gain and survival) were measured. Significant differences were not detected between treatment groups, but sample size was likely too small to provide sufficient power. The second study is a case series in which some calves were administered IP fluids (McSherry & Ginyer, 1954). An association between fluid therapy and clinical outcomes was not investigated.
Therefore, these studies do not provide evidence that IP fluids lead to comparable or superior clinical improvement when compared to IV fluid therapy in moderately to severely dehydrated or acidaemic calves.
Summary of the evidence
Population: | Male Holstein calves aged 1–16 days with clinical dehydration (6–8 %) and an inability to suck, resident on a Californian calf ranch |
Sample size: | 55 calves |
Intervention details: |
|
Study design: | Experimental, randomised, controlled trial |
Outcome Studied: |
|
Main Findings (relevant to PICO question): |
|
Limitations: | Study design and reporting:
Power analysis:
Assessment of bias:
|
Population: | Jersey, Shorthorn and Holstein Friesian calves with diarrhoea, admitted to the Ambulatory Clinic of the Ontario Veterinary College, Canada. Median age was 12.5 days (range 7–90 days). Sex was not specified. |
Sample size: | 18 calves (Jersey = 7, Shorthorn = 7, Holstein Friesian = 4) |
Intervention details: |
|
Study design: | Case series |
Outcome Studied: |
|
Main Findings (relevant to PICO question): |
None that were relevant to the PICO |
Limitations: |
|
Appraisal, application and reflection
Although intraperitoneal fluid therapy for dehydrated calves has been suggested as equivalent, of greater benefit or of less benefit than other methods of fluid administration, or potentially harmful, these suggestions are not evidence-based.
For example, Roussel (1983) proposed that IP fluid administration was equivalent to oral fluid therapy if dehydration was <8 %. Vermunt (1994) supported this opinion, stating that IV fluids should be administered if dehydration is >8%. Reasons suggested for equivalency or of greater benefit than other methods of fluid administration include the potential for administration of large volumes (Lewis & Phillips, 1971) and that IP administration might be a useful method to deliver fluids to the interstitial and intracellular compartments of young animals (Edwards & Williams, 1972).
In contrast, Radostits (1965) suggested that IP fluid therapy was not beneficial, but stated that this might be due to administration of insufficient volume, and Watt (1967) proposed that it was unsuitable due to the risk of adhesions. Phillips (1985) commented that there were good reasons that IP fluids were not commonly used (without further discussion), and Dickson (1987) recommended that only IV fluids were of benefit in severely dehydrated calves because IP absorption was ineffective. This was reiterated by Michell (1988) who stated that there is no real alternative to IV fluid administration for severe dehydration. More recently, Constable (2003) and González-Montaña et al. (2017) also mention the potential use of IP fluids in cattle and highlight similar risks.
Only two studies were found which claimed to assess intraperitoneal fluid administration of electrolyte solutions to treat dehydration in calves (Koenig et al., 1995 and McSherry & Grinyer, 1954). In the study by Koenig et al. (1995), authors assessed outcomes in calves at 28 and 60 days post-treatment with IP or IV fluids between 1–16 days old. Although they suggested that IP fluid administration was useful to treat dehydration in young calves (several Californian calf ranches were using this method to administer fluids) this evidence was not presented because it was not the focus of their study. In the study by McSherry & Grinyer (1954), the authors presented clinical and haematological findings from a series of cases in which dehydrated calves were treated with combinations of antibiotics and oral, IP and IV fluids. The clinical benefit of IP fluids relative to IV fluids was not assessed. Importantly, the two studies presented here also did not provide evidence that IP fluid administration does not cause harm (for example, peritonitis).
Overall, we found that there is no evidence to support the use of IP fluids to treat moderate to severe dehydration and acidaemia in calves. Given the lower expected non-clinical costs of IP fluids relative to IV fluids (labour and time) we suggest studies to investigate the safety and clinical benefits of IP fluid administration in calves for this purpose are needed. We propose that IP fluids might be used earlier than intravenous fluid therapy in dehydrated acidaemic calves due to the lower non-clinical costs.
Methodology Section
Search Strategy | |
Databases searched and dates covered: | CAB Abstracts on OVID Platform (1973 – Week 27 2018)
Scopus |
Search strategy: | CAB Abstracts:
Scopus: (TITLE-ABS-KEY("fluid therapy" OR "rehydration therapy" OR intraperitoneal OR intra-peritoneal OR transabdominal OR intra-abdominal OR intraabdominal OR parenteral OR "intravenous injection" OR "iv injection")) AND (TITLE-ABS-KEY(calf OR calve*)) AND (TITLE-ABS-KEY(diarrh* OR dehydrat*))
Article references: If intra-peritoneal fluid administration was mentioned within reviewed articles, the cited references were also included. |
Dates searches performed: | 18 Jul 2018 |
Exclusion / Inclusion Criteria | |
Exclusion: | No mention of intraperitoneal fluid therapy/administration in the title or abstract OR no survey or study occurred.
Literature in languages other than English. |
Inclusion: | A survey or study in which calves were treated with intraperitoneal administration of an electrolyte solution. |
Search Outcome | ||||||
Database |
Number of results |
Excluded – Duplicated in both searches, so removed |
Excluded – No mention of intraperitoneal fluid administration in the title or abstract |
Excluded – No study carried out |
Total relevant papers |
|
CAB Abstracts on OVID Platform |
323 | 0 | 312 | 11 | 0 | |
Scopus |
182 | 103 | 79 | 0 | 0 | |
Cited references from included searched articles |
2 | 0 | 0 | 0 | 2 | |
Total relevant papers when duplicates removed |
2 |
The authors declare no conflicts of interest.
The authors gratefully acknowledge the library assistance of Lee-Anne McInerney (Charles Sturt University), Bridget Sheppard and Clare Boulton (RCVS).
Intellectual Property Rights
Authors of Knowledge Summaries submitted to RCVS Knowledge for publication will retain copyright in their work, and will be required to grant to RCVS Knowledge a non-exclusive licence to publish including but not limited to the right to publish, re-publish, transmit, sell, distribute and otherwise use the materials in all languages and all media throughout the world, and to licence or permit others to do so.
Disclaimer
Knowledge Summaries are a peer-reviewed article type which aims to answer a clinical question based on the best available current evidence. It does not override the responsibility of the practitioner. Informed decisions should be made by considering such factors as individual clinical expertise and judgement along with patient’s circumstances and owners’ values. Knowledge Summaries are a resource to help inform and any opinions expressed within the Knowledge Summaries are the author's own and do not necessarily reflect the view of the RCVS Knowledge. Authors are responsible for the accuracy of the content. While the Editor and Publisher believe that all content herein are in accord with current recommendations and practice at the time of publication, they accept no legal responsibility for any errors or omissions, and make no warranty, express or implied, with respect to material contained within. For further information please refer to our Terms of Use.